233 related articles for article (PubMed ID: 31166506)
21. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
[TBL] [Abstract][Full Text] [Related]
22. Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland.
Schmitz S; McCullagh L; Adams R; Barry M; Walsh C
Pharmacoeconomics; 2016 Sep; 34(9):925-37. PubMed ID: 27034245
[TBL] [Abstract][Full Text] [Related]
23. Decision criteria for resource allocation: an analysis of CONITEC oncology reports.
Campolina AG; Yuba TY; Soárez PC
Cien Saude Colet; 2022 Jul; 27(7):2563-2572. PubMed ID: 35730828
[TBL] [Abstract][Full Text] [Related]
24. Mapping of health technology assessment in selected countries.
Oortwijn W; Broos P; Vondeling H; Banta D; Todorova L
Int J Technol Assess Health Care; 2013 Oct; 29(4):424-34. PubMed ID: 24290336
[TBL] [Abstract][Full Text] [Related]
25. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
26. Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.
Xie F; Bowen JM; Sutherland SC; Burke N; Blackhouse G; Tarride JE; O'Reilly D; Goeree R
Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):513-21. PubMed ID: 21958096
[TBL] [Abstract][Full Text] [Related]
27. Health technology assessment to improve the medical equipment life cycle management.
Margotti AE; Ferreira FB; Santos FA; Garcia R
Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():354-7. PubMed ID: 24109697
[TBL] [Abstract][Full Text] [Related]
28. Is there an alternative to quality-adjusted life years for supporting healthcare decision making?
Beresniak A; Dupont D
Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):351-7. PubMed ID: 27139424
[TBL] [Abstract][Full Text] [Related]
29. Health technology reassessment in the Brazilian public health system: Analysis of the current status.
Pereira VC; Barreto JOM; Neves FADR
PLoS One; 2019; 14(7):e0220131. PubMed ID: 31356609
[TBL] [Abstract][Full Text] [Related]
30. Incorporation of new medicines by the National Commission for Incorporation of Technologies, 2012 to June 2016.
Caetano R; Silva RMD; Pedro ÉM; Oliveira IAG; Biz AN; Santana P
Cien Saude Colet; 2017 Aug; 22(8):2513-2525. PubMed ID: 28793068
[TBL] [Abstract][Full Text] [Related]
31. International diffusion of new health technologies: a ten-country analysis of six health technologies.
Packer C; Simpson S; Stevens A;
Int J Technol Assess Health Care; 2006; 22(4):419-28. PubMed ID: 16984674
[TBL] [Abstract][Full Text] [Related]
32. HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL, EASTERN, AND SOUTH EUROPEAN COUNTRIES: CROATIA.
Huic M; Tandara Hacek R; Svajger I
Int J Technol Assess Health Care; 2017 Jan; 33(3):376-383. PubMed ID: 28803589
[TBL] [Abstract][Full Text] [Related]
33. Basics of health technology assessment.
O'Reilly D; Campbell K; Goeree R;
Methods Mol Biol; 2009; 473():263-83. PubMed ID: 19160744
[TBL] [Abstract][Full Text] [Related]
34. Assessing the international use of health technology assessments: exploring the merits of different methods when applied to the National Institute of Health Research Health Technology Assessment (NIHR HTA) programme.
Wright D; Milne R; Price A; Tose N
Int J Technol Assess Health Care; 2013 Apr; 29(2):192-7. PubMed ID: 23552058
[TBL] [Abstract][Full Text] [Related]
35. The Value of Medicines: A Crucial but Vague Concept.
Antoñanzas F; Terkola R; Postma M
Pharmacoeconomics; 2016 Dec; 34(12):1227-1239. PubMed ID: 27444306
[TBL] [Abstract][Full Text] [Related]
36. [Health technology assessment: experience in the Ministry of Health of Brazil].
Silva MT
Rev Peru Med Exp Salud Publica; 2011; 28(3):548-51. PubMed ID: 22086639
[TBL] [Abstract][Full Text] [Related]
37. Health technology assessment and primary data collection for reducing uncertainty in decision making.
Goeree R; Levin L; Chandra K; Bowen JM; Blackhouse G; Tarride JE; Burke N; Bischof M; Xie F; O'Reilly D
J Am Coll Radiol; 2009 May; 6(5):332-42. PubMed ID: 19394574
[TBL] [Abstract][Full Text] [Related]
38. IMPACT OF HEALTH TECHNOLOGY ASSESSMENT REPORTS ON HOSPITAL DECISION MAKERS - 10-YEAR INSIGHT FROM A HOSPITAL UNIT IN SHERBROOKE, CANADA: IMPACT OF HEALTH TECHNOLOGY ASSESSMENT ON HOSPITAL DECISIONS.
Poder TG; Bellemare CA; Bédard SK; Fisette JF; Dagenais P
Int J Technol Assess Health Care; 2018 Jan; 34(4):393-399. PubMed ID: 30021663
[TBL] [Abstract][Full Text] [Related]
39. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.
Oortwijn W; Mathijssen J; Banta D
Health Policy; 2010 May; 95(2-3):174-84. PubMed ID: 20074829
[TBL] [Abstract][Full Text] [Related]
40. INFLUENCE OF HEALTH TECHNOLOGY ASSESSMENT AND ITS MEASUREMENT.
Hailey D; Werkö S; Rosén M; Macpherson K; Myles S; Gallegos Rivero V; Hipólito-Olivares C; Sihvo S; Pwu J; Yang WW; Chen YC; Perez Galán A; Aleman A; Villamil E
Int J Technol Assess Health Care; 2016 Jan; 32(6):376-384. PubMed ID: 28124969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
